Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001493152-24-042291
Filing Date
2024-10-24
Accepted
2024-10-24 06:07:06
Documents
76

Document Format Files

Seq Description Document Type Size
1 forms-4a.htm   iXBRL S-4/A 9403247
2 ex5-1.htm EX-5.1 37281
3 ex8-1.htm EX-8.1 29476
4 ex23-1.htm EX-23.1 4392
5 ex23-2.htm EX-23.2 6162
6 ex98-1.htm EX-98.1 118197
7 CALCULATION OF FILING FEE TABLE ex107.htm EX-FILING FEES 48900
8 annexh_001.jpg GRAPHIC 16282
9 ex8-1_001.jpg GRAPHIC 8551
10 ex98-1_001.jpg GRAPHIC 15343
11 ex5-1_001.jpg GRAPHIC 16371
12 ex23-2_001.jpg GRAPHIC 63272
13 ex23-2_002.jpg GRAPHIC 38850
  Complete submission text file 0001493152-24-042291.txt   18259371

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE pwup-20240630.xsd EX-101.SCH 59473
15 XBRL CALCULATION FILE pwup-20240630_cal.xml EX-101.CAL 53888
16 XBRL DEFINITION FILE pwup-20240630_def.xml EX-101.DEF 424265
17 XBRL LABEL FILE pwup-20240630_lab.xml EX-101.LAB 440462
18 XBRL PRESENTATION FILE pwup-20240630_pre.xml EX-101.PRE 420210
80 EXTRACTED XBRL INSTANCE DOCUMENT forms-4a_htm.xml XML 1706404
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-281991 | Film No.: 241390503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 194 CANDELARO DRIVE #223 HUMACAO PR 00791
Business Address 194 CANDELERO DRIVE SUITE 223 HUMACAO PR 00791 (415)-592-7399
Aspire BioPharma Inc. (Filer) CIK: 0001995528 (see all company filings)

EIN.: 660991341 | State of Incorp.: PR | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-281991-01 | Film No.: 241390504